Susan Cornell

572 total citations
24 papers, 443 citations indexed

About

Susan Cornell is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Susan Cornell has authored 24 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Susan Cornell's work include Diabetes Treatment and Management (15 papers), Diabetes Management and Research (12 papers) and Pharmacology and Obesity Treatment (4 papers). Susan Cornell is often cited by papers focused on Diabetes Treatment and Management (15 papers), Diabetes Management and Research (12 papers) and Pharmacology and Obesity Treatment (4 papers). Susan Cornell collaborates with scholars based in United States, Italy and Ireland. Susan Cornell's co-authors include Dilip Amin, Mark H. Perrone, Glenda E. Bilder, Curtis Triplitt, Nalini Chandar, Susan M. Viselli, Bryan C. Bjork, Sophie La Salle, Sean M. Lynch and Lon J. Van Winkle and has published in prestigious journals such as Health Policy, American Journal of Pharmaceutical Education and Pharmacology.

In The Last Decade

Susan Cornell

23 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan Cornell United States 11 212 119 89 60 57 24 443
M. Dominique Ashen United States 13 156 0.7× 147 1.2× 138 1.6× 27 0.5× 83 1.5× 23 628
Paula D. Giesler United States 9 444 2.1× 133 1.1× 217 2.4× 36 0.6× 40 0.7× 9 576
Lucianne Righeti Monteiro Tannus Brazil 7 238 1.1× 103 0.9× 96 1.1× 25 0.4× 34 0.6× 16 524
Kyriakos Kazakos Greece 11 223 1.1× 83 0.7× 62 0.7× 19 0.3× 52 0.9× 28 474
Koichi Hashimoto Japan 14 111 0.5× 70 0.6× 82 0.9× 24 0.4× 55 1.0× 46 500
Hernán García Chile 15 270 1.3× 137 1.2× 145 1.6× 47 0.8× 134 2.4× 42 578
Jeong‐Ah Shin South Korea 5 178 0.8× 77 0.6× 87 1.0× 24 0.4× 41 0.7× 6 376
Hyun Shik Son South Korea 12 289 1.4× 155 1.3× 68 0.8× 62 1.0× 31 0.5× 43 573
María Tinajero Canada 4 119 0.6× 116 1.0× 66 0.7× 24 0.4× 80 1.4× 10 459
Ville Salaspuro Finland 10 86 0.4× 177 1.5× 86 1.0× 89 1.5× 39 0.7× 14 630

Countries citing papers authored by Susan Cornell

Since Specialization
Citations

This map shows the geographic impact of Susan Cornell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Cornell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Cornell more than expected).

Fields of papers citing papers by Susan Cornell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Cornell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Cornell. The network helps show where Susan Cornell may publish in the future.

Co-authorship network of co-authors of Susan Cornell

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Cornell. A scholar is included among the top collaborators of Susan Cornell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Cornell. Susan Cornell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Xiaowu, et al.. (2024). Pen needle use patterns in an insured population with diabetes: U.S. retrospective claims analysis. Journal of the American Pharmacists Association. 64(4). 102124–102124. 1 indexed citations
2.
Cornell, Susan. (2022). Diabetes, Part 1: Disease State Review. The Senior Care Pharmacist. 37(4). 139–145. 2 indexed citations
3.
Cornell, Susan. (2020). A review of GLP‐1 receptor agonists in type 2 diabetes: A focus on the mechanism of action of once‐weekly agents. Journal of Clinical Pharmacy and Therapeutics. 45(S1). 17–27. 100 indexed citations
4.
Cornell, Susan. (2016). The Use of Insulin in Diabetes Management: The Next Generation: Preface. Diabetes Spectrum. 29(3). 133–134.
5.
Cornell, Susan. (2015). Continual evolution of type 2 diabetes: an update on pathophysiology and emerging treatment options. Therapeutics and Clinical Risk Management. 11. 621–621. 36 indexed citations
6.
Triplitt, Curtis & Susan Cornell. (2015). Canagliflozin Treatment in Patients with Type 2 Diabetes Mellitus. Clinical Medicine Insights Endocrinology and Diabetes. 8. CMED.S31526–CMED.S31526. 23 indexed citations
7.
Cornell, Susan & Jennifer D’Souza. (2014). Pharmacotherapy Considerations in Diabetes and Obesity: Setting Patients up for Success. Postgraduate Medicine. 126(2). 100–109. 4 indexed citations
8.
Cornell, Susan. (2014). Type 2 Diabetes Treatment Recommendations Update: Appropriate Use of Dipeptidyl Peptidase-4 Inhibitors. Journal of Diabetes & Metabolism. 5(8). 6 indexed citations
9.
Winkle, Lon J. Van, Susan Cornell, Nancy Fjortoft, et al.. (2013). Critical Thinking and Reflection Exercises in a Biochemistry Course to Improve Prospective Health Professions Students’ Attitudes Toward Physician-Pharmacist Collaboration. American Journal of Pharmaceutical Education. 77(8). 169–169. 32 indexed citations
10.
Cornell, Susan. (2012). Differentiating among incretin therapies: a multiple-target approach to type 2 diabetes. Journal of Clinical Pharmacy and Therapeutics. 37(5). 510–524. 33 indexed citations
11.
Winkle, Lon J. Van, Bryan C. Bjork, Nalini Chandar, et al.. (2012). Interprofessional Workshop to Improve Mutual Understanding Between Pharmacy and Medical Students. American Journal of Pharmaceutical Education. 76(8). 150–150. 39 indexed citations
12.
Cornell, Susan, et al.. (2012). Diabetes Pharmacotherapy in 2012: Considerations in Medication Selection. Postgraduate Medicine. 124(4). 84–94. 14 indexed citations
13.
Cornell, Susan. (2011). Key considerations in pharmacotherapy for type 2 diabetes mellitus: a multiple target organ approach. Journal of Clinical Pharmacy and Therapeutics. 37(3). 254–259. 6 indexed citations
14.
Cornell, Susan, June M. McKoy, Nancy A. Letassy, et al.. (2011). Taking medication in diabetes self-management: Issues and recommendations for reducing barriers. 3(5). 263–271. 1 indexed citations
15.
Cornell, Susan. (2010). Managing diabetes-related costs and quality of life issues: Value of insulin analogs and pens for inpatient use. Health Policy. 96(3). 191–199. 5 indexed citations
16.
Cornell, Susan, et al.. (2007). Pay for Performance: Where's The Return?. Journal of Managed Care Pharmacy. 13(2 Supp B). 1–24. 1 indexed citations
17.
Cornell, Susan, et al.. (2004). Self-monitoring Blood Glucose (SMBG): Now and the Future. Journal of Pharmacy Practice. 17(1). 29–38. 17 indexed citations
18.
Cornell, Susan. (1997). Alternatives to hormone replacement therapy. Do they measure up to estrogen?. PubMed. 5(7). 45–6, 49, 72. 1 indexed citations
19.
Amin, Dilip, Susan Cornell, Mark H. Perrone, & Glenda E. Bilder. (1996). 1-Hydroxy-3-(methylpentylamino)-propylidene-1,1-bisphosphonic acid as a potent inhibitor of squalene synthase.. PubMed. 46(8). 759–62. 50 indexed citations
20.
Amin, Dilip, et al.. (1993). RG 12561 (Dalvastatin): A Novel Synthetic Inhibitor of HMG-CoA Reductase and Cholesterol-Lowering Agent. Pharmacology. 46(1). 13–22. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Dominique Ashen Breakdown of academic impact, for papers by Paula D. Giesler Breakdown of academic impact, for papers by Lucianne Righeti Monteiro Tannus Breakdown of academic impact, for papers by Kyriakos Kazakos Breakdown of academic impact, for papers by Koichi Hashimoto Breakdown of academic impact, for papers by Hernán García Breakdown of academic impact, for papers by Jeong‐Ah Shin Breakdown of academic impact, for papers by Hyun Shik Son Breakdown of academic impact, for papers by María Tinajero Breakdown of academic impact, for papers by Ville Salaspuro
Rankless by CCL
2026